Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PG-11047 2HCl is an apoptosis-stimulating agent used in the treatment of genitourinary disorders, immune system disorders, genetic disorders and malformations, ocular disorders, and disorders of the blood and lymphatic systems, and in the study of lymphomas and prostate cancer.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 26,000 | |||
5 mg | 在庫あり | ¥ 77,000 | |||
10 mg | 在庫あり | ¥ 123,500 | |||
25 mg | 在庫あり | ¥ 199,500 | |||
50 mg | 在庫あり | ¥ 273,500 | |||
100 mg | 在庫あり | ¥ 365,000 | |||
500 mg | 在庫あり | ¥ 739,000 |
説明 | PG-11047 2HCl is an apoptosis-stimulating agent used in the treatment of genitourinary disorders, immune system disorders, genetic disorders and malformations, ocular disorders, and disorders of the blood and lymphatic systems, and in the study of lymphomas and prostate cancer. |
In vitro |
PG-11047 2HCl (13 nM-5 mM; 72 h) inhibits the growth of members of a broad range of mammary cell lineages, with basal-like cell lines being inhibited at lower concentrations than luminal cell lines.[1] PG-11047 2HCl (0.3, 10, 300 μM; 48 h, 72 h) shows a significant reduction in S-phase fraction at doses that produce little apoptosis.[1] |
別名 | PG-11047 2HCl(949933-50-0 Free base), CGC-11047 2HCl |
分子量 | 329.35 |
分子式 | C14H34Cl2N4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.62 mg/mL (14.01 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PG-11047 2HCl Apoptosis CGC11047 PG-11047 2HCl(949933-50-0 Free base) CGC 11047 CGC-11047 CGC-11047 2HCl PG11047 PG-11047 PG 11047 Inhibitor inhibitor inhibit